Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuelle Verger

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Leukemia|July 11, 2023
Clinical features and genomic landscape of myeloproliferative neoplasm (MPN) patients with autoimmune and inflammatory diseases (AID)Dikelele Elessa, Lin-Pierre Zhao, Rafael Daltro de Oliveira, et al.
American Journal of Hematology|January 27, 2024
Comparative clinical and molecular landscape of primary and secondary myelofibrosis: Superior performance of MIPSS70+ v2.0 over MYSEC-PMMatteo Guerra, Hélène Pasquer, Rafael Daltro de Oliveira, et al.
Blood Advances|August 11, 2020
Molecular profiling and risk classification of patients with myeloproliferative neoplasms and splanchnic vein thrombosesPierre-Edouard Debureaux, Bruno Cassinat, Juliette Soret-Dulphy, et al.
Blood|May 4, 2021
Impact of NFE2 mutations on AML transformation and overall survival in patients with myeloproliferative neoplasmsClémence Marcault, Lin-Pierre Zhao, Nabih Maslah, et al.
Haematologica|July 9, 2026
Genetic screening of triple negative thrombocytosis patients identifies germline <i>MPL</i> compound mutations and <i>SH2B3/LNK</i> truncating mutationsBruno Cassinat, Louise Lecordier, Sarah Awan-Toor, et al.
Blood Advances|February 22, 2024
Exacerbation of thromboinflammation by JAK2V617F mutation worsens the prognosis of cerebral venous sinus thrombosisMarie-Charlotte Bourrienne, Véronique Le Cam Duchez, Dorothée Faille, et al.
Leukemia|December 26, 2023
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratificationHélène Pasquer, Rafael Daltro de Oliveira, Loic Vasseur, et al.
Nature Communications|July 7, 2025
JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasmsNabih Maslah, Nina Kaci, Blandine Roux, et al.
Nature Genetics|October 13, 2015
Juvenile myelomonocytic leukemia displays mutations in components of the RAS pathway and the PRC2 networkAurélie Caye, Marion Strullu, Fabien Guidez, et al.
Leukemia|June 18, 2025
A molecular signature predicts hematologic evolution in polycythemia vera patientsOlivier Mansier, Eric Lippert, Lina Benajiba, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Leukemia|July 11, 2023
Clinical features and genomic landscape of myeloproliferative neoplasm (MPN) patients with autoimmune and inflammatory diseases (AID)Dikelele Elessa, Lin-Pierre Zhao, Rafael Daltro de Oliveira, et al.
American Journal of Hematology|January 27, 2024
Comparative clinical and molecular landscape of primary and secondary myelofibrosis: Superior performance of MIPSS70+ v2.0 over MYSEC-PMMatteo Guerra, Hélène Pasquer, Rafael Daltro de Oliveira, et al.
Blood Advances|August 11, 2020
Molecular profiling and risk classification of patients with myeloproliferative neoplasms and splanchnic vein thrombosesPierre-Edouard Debureaux, Bruno Cassinat, Juliette Soret-Dulphy, et al.
Blood|May 4, 2021
Impact of NFE2 mutations on AML transformation and overall survival in patients with myeloproliferative neoplasmsClémence Marcault, Lin-Pierre Zhao, Nabih Maslah, et al.
Haematologica|July 9, 2026
Genetic screening of triple negative thrombocytosis patients identifies germline <i>MPL</i> compound mutations and <i>SH2B3/LNK</i> truncating mutationsBruno Cassinat, Louise Lecordier, Sarah Awan-Toor, et al.
Blood Advances|February 22, 2024
Exacerbation of thromboinflammation by JAK2V617F mutation worsens the prognosis of cerebral venous sinus thrombosisMarie-Charlotte Bourrienne, Véronique Le Cam Duchez, Dorothée Faille, et al.
Leukemia|December 26, 2023
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratificationHélène Pasquer, Rafael Daltro de Oliveira, Loic Vasseur, et al.
Nature Communications|July 7, 2025
JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasmsNabih Maslah, Nina Kaci, Blandine Roux, et al.
Nature Genetics|October 13, 2015
Juvenile myelomonocytic leukemia displays mutations in components of the RAS pathway and the PRC2 networkAurélie Caye, Marion Strullu, Fabien Guidez, et al.
Leukemia|June 18, 2025
A molecular signature predicts hematologic evolution in polycythemia vera patientsOlivier Mansier, Eric Lippert, Lina Benajiba, et al.
Pageof 4